BioAnalytix
BioAnalytix LLC: A biotech firm specializing in large-molecule biologic drug and biosimilar analysis.
Founded
2012BioAnalytix LLC: A biotech firm specializing in large-molecule biologic drug and biosimilar analysis.
Founded in Atkinson, New Hampshire, BioAnalytix LLC is a biotechnology company dedicated to the analysis and characterization of large-molecule biologic drugs and biosimilars. The company's core mission is to enhance the development and quality of biologic therapeutics through advanced analytical services. BioAnalytix offers a range of services including product characterization, attribute analysis, process development, manufacturing quality control, and clinical sample analysis. Their market focus includes pharmaceutical companies developing biologic drugs and biosimilars.
Notable affiliated individuals include experts in biotechnology and pharmaceutical analytics, although specific names are not provided. BioAnalytix has achieved significant milestones in the field of biologic drug analytics, contributing to the successful development and approval of various biologic therapeutics. The company's impact is evident in its role in improving drug safety, efficacy, and regulatory compliance, thereby advancing the overall quality of healthcare treatments involving biologics.
Companies similar to BioAnalytix include BioAnalytics, Analiza, Pyxant Labs and Accium BioSciences.
BioAnalytix was founded in 2012.
BioAnalytix's headquarters is located in Boston, MA, US.
BioAnalytix's most recent funding round was for $3.8M (USD) in October 2013.
As of Oct 24, 2013, BioAnalytix has disclosed funding of $4.6M (USD). Undisclosed round amounts are excluded.
BioAnalytix has 30 employees as of Feb 5, 2024.
Accium BioSciences
